UNSPSC 51161574: Tiotropium bromide

This classification denotes an antimuscarinic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L64SXO195N. European Medicines Agency schedules Tiotropium bromide monohydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21897. Tiotropium bromide generally arises in the molecular formula C19H22NO4S2.BR.H2O. The term 'tiotropium bromide' is a European Pharmacopoeia designation. Most nations, for tariff and trade purposes, schedule tiotropium bromide under HS 29399900 and SITC 54149.

As of Q4 2014, TIOTROPIUM BROMIDE remains US FDA's Preferred Term for this commodity. Tiotropium bromide bears US NLM identifiers UMLS ID CL449040 and NCI Concept Code C84608. SMILES: C[N+]1([C@@H]2C[C@H](C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4CCCS4)(C5CCCS5)O)C.[BR-].

UNSPSC 51161574 Tiotropium bromide is a Commodity code for a specific pharmaceutical active ingredient used in respiratory maintenance therapy, chiefly for chronic obstructive pulmonary disease and asthma management. State and local governments procure tiotropium bromide formulations primarily through their Medicaid programs, state health departments, correctional health systems, and public hospital networks. The drug is typically acquired as a finished inhalation powder or solution rather than as a raw active pharmaceutical ingredient, and purchasing patterns reflect standard pharmaceutical procurement cycles tied to formulary adoption, volume rebates, and manufacturer pricing agreements.

The source material contains no recent state or local contract opportunities tagged under this code and does not identify specific issuing bodies, jurisdictions, or response dates. Without documented recent solicitation activity, current market signals for tiotropium bromide procurement under this code are not available.